Drug Trial Radar · NCT03635372
A Comparison of Effectiveness of Oral Sucrolfate, Alginate and Hydrotalcide in Dispeptic Pain Treatment
Last checked: Nov 20, 2026Latest source record: Aug 31, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
300
Actual
Start
Jun 20, 2017
Primary completion
Oct 22, 2017
Study completion Nov 25, 2017
Sponsor
- Lead sponsor
- Pamukkale UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Aug 17, 2018
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Factorial
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 60 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Dyspepsia is a very common but non-specific complaint that may indicate a group of symptoms that can be attributed to the upper gastrointestinal system, such as epigastric discomfort, abdominal bloating or fullness, stomach upset and nausea or vomiting that may be associated with food. This study aimed to improve treatment management of patients with complaints of dyspeptic pain and emergency services, and to compare treatment efficacy of oral sucralfate, alginate and hydrotalcite, which are widely used in our country. Literature According to our research, our study is the first study to compare different antacids in our study of emergency serviste dyspepsia.
Conditions
- Dyspepsia
Interventions
AlginateDrug
10 cc of Alginate peroral
SucralfateDrug
10 cc of Sucralfate peroral
HydrotalciteDrug
10 cc of Hydrotalcite peroral
Primary outcomes
What the sponsor says the trial is designed to measure.
- Relief of Gastric PainTime frame: Change from baseline in dispeptic complaint VAS scores at 60 minutes
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Pamukkale University
Denizli, Turkey (Türkiye)
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.